Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists

被引:11
作者
Matsui, Yumi [1 ]
Yamaguchi, Takahiro [2 ]
Yamazaki, Takanori [2 ]
Yoshida, Masayuki [2 ]
Arai, Masami [2 ]
Terasaka, Naoki [2 ]
Honzumi, Shoko [2 ]
Wakabayashi, Kenji [1 ]
Hayashi, Shinko [2 ]
Nakai, Daisuke [2 ]
Hanzawa, Hiroyuki [1 ]
Tamaki, Kazuhiko [2 ]
机构
[1] Daiichi Sankyo RD Novare Co Ltd, Edogawa Ku, Tokyo 1348630, Japan
[2] Daiichi Sankyo Co Ltd, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan
关键词
Liver X receptors; LXR agonists; Atherosclerosis; tert-Butyl benzoate; Structure-based drug design; CELLULAR CHOLESTEROL EFFLUX; MITSUNOBU REACTION; NUCLEAR-RECEPTOR; LXR-ALPHA; LIGAND; ATHEROSCLEROSIS; MICE; EXPRESSION; REAGENT; AMINES;
D O I
10.1016/j.bmcl.2015.07.047
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To obtain potent liver X receptor (LXR) agonists, a structure-activity relationship study was performed on a series of tert-butyl benzoate analogs. As the crystal structure analysis suggested applicable interactions between the LXR ligand-binding domain and the ligands, two key functional groups were introduced. The introduction of the hydroxyl group on the C6-position of the benzoate part enhanced the agonistic activity in a cell-based assay, and the carboxyl group in terminal improved the pharmacokinetic profile in mice, respectively. The obtained compound 32b increased blood ABCA1 mRNA expression without plasma TG elevation in both mice and cynomolgus monkeys. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3914 / 3920
页数:7
相关论文
共 33 条
[1]   The ABCs of sterol transport [J].
Baldan, Angel ;
Bojanic, Dragana D. ;
Edwards, Peter A. .
JOURNAL OF LIPID RESEARCH, 2009, 50 :S80-S85
[2]  
Bradley M. N., 2005, DRUG DISCOV TODAY TH, V2, P97, DOI [10.1016/j.ddstr.2005.05.018, DOI 10.1016/J.DDSTR.2005.05.018]
[3]   Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoE [J].
Bradley, Michelle N. ;
Hong, Cynthia ;
Chen, Mingyi ;
Joseph, Sean B. ;
Wilpitz, Damien C. ;
Wang, Xuping ;
Lusis, Aldons J. ;
Collins, Allan ;
Hseuh, Willa A. ;
Collins, Jon L. ;
Tangirala, Rajendra K. ;
Tontonoz, Peter .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (08) :2337-2346
[4]   Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles [J].
Chu, L ;
Hutchins, JE ;
Weber, AE ;
Lo, JL ;
Yang, YT ;
Cheng, K ;
Smith, RG ;
Fisher, MH ;
Wyvratt, MJ ;
Goulet, MT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (04) :509-513
[5]   Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines [J].
Collins, JL ;
Fivush, AM ;
Watson, MA ;
Galardi, CM ;
Lewis, MC ;
Moore, LB ;
Parks, DJ ;
Wilson, JG ;
Tippin, TK ;
Binz, JG ;
Plunket, KD ;
Morgan, DG ;
Beaudet, EJ ;
Whitney, KD ;
Kliewer, SA ;
Willson, TM .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) :1963-1966
[6]  
Collins JL, 2004, CURR OPIN DRUG DISC, V7, P692
[7]   The synthesis and use in asymmetric epoxidation of metal salen complexes derived from enantiopure trans-cyclopentane- and cyclobutane-1,2-diamine [J].
Daly, AM ;
Gilheany, DG .
TETRAHEDRON-ASYMMETRY, 2003, 14 (01) :127-137
[8]   The three-dimensional structure of the liver X receptor β reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands [J].
Färnegårdh, M ;
Bonn, T ;
Sun, S ;
Ljunggren, J ;
Ahola, H ;
Wilhelmsson, A ;
Gustafsson, JÅ ;
Carlquist, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :38821-38828
[9]   STUDIES ON THE MECHANISM OF TOXICITY OF ACETAMINOPHEN - SYNTHESIS AND REACTIONS OF N-ACETYL-2,6-DIMETHYL-PARA-BENZOQUINONE AND N-ACETYL-3,5-DIMETHYL-PARA-BENZOQUINONE IMINES [J].
FERNANDO, CR ;
CALDER, IC ;
HAM, KN .
JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (11) :1153-1158
[10]   Minireview: Liver X Receptor β: Emerging Roles in Physiology and Diseases [J].
Gabbi, Chiara ;
Warner, Margaret ;
Gustafsson, Jan-Ake .
MOLECULAR ENDOCRINOLOGY, 2009, 23 (02) :129-136